GBT
ELV icon

Grove Bank & Trust’s Elevance Health ELV Stock Holding History

Grove Bank & Trust’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19M Sell
3,068
-526
-15% -$195K 0.12% 106
2026
Q1 		$1.05M Buy
3,594
+771
+27% +$253K 0.12% 107
2025
Q4 		$990K Sell
2,823
-403
-12% -$136K 0.11% 118
2025
Q3 		$1.04M Buy
3,226
+63
+2% +$19.6K 0.12% 110
2025
Q2 		$1.23M Buy
3,163
+551
+21% +$222K 0.15% 97
2025
Q1 		$1.14M Buy
2,612
+37
+1% +$14.9K 0.15% 99
2024
Q4 		$950K Buy
2,575
+2,008
+354% +$840K 0.13% 103
2024
Q3 		$295K Sell
567
-104
-15% -$55.6K 0.04% 184
2024
Q2 		$364K Sell
671
-16
-2% -$8.46K 0.06% 162
2024
Q1 		$356K Hold
687
– – 0.06% 166
2023
Q4 		$324K Buy
687
+24
+4% +$11.1K 0.06% 173
2023
Q3 		$289K Buy
663
+146
+28% +$66.2K 0.06% 179
2023
Q2 		$230K Buy
517
+14
+3% +$6.46K 0.05% 197
2023
Q1 		$231K Buy
503
+52
+12% +$24.7K 0.05% 197
2022
Q4 		$231K Hold
451
– – 0.05% 201
2022
Q3 		$205K Buy
451
+8
+2% +$3.83K 0.05% 201
2022
Q2 		$214K Hold
443
– – 0.05% 201
2022
Q1 		$218K Buy
+443
New +$202K 0.04% 216
2018
Q1 		– Sell
-298
Closed -$67K – 254
2017
Q4 		$67K Sell
298
-90
-23% -$19.2K 0.03% 265
2017
Q3 		$74K Buy
388
+242
+166% +$46.1K 0.04% 253
2017
Q2 		$27K Buy
146
+90
+161% +$16.2K 0.02% 341
2017
Q1 		$9K Sell
56
-300
-84% -$47.7K 0.01% 350
2016
Q4 		$51K Buy
356
+56
+19% +$7.5K 0.04% 213
2016
Q3 		$38K Hold
300
– – 0.03% 165
2016
Q2 		$39K Hold
300
– – 0.03% 163
2016
Q1 		$42K Hold
300
– – 0.04% 170
2015
Q4 		$42K Buy
+300
New +$41.3K 0.04% 188

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Grove Bank & Trust's ELV Position: Q2 2026 in Review

Grove Bank & Trust reduced its Elevance Health (ELV) stake by 15% in Q2 2026, selling an estimated $195K and leaving 3,068 shares worth $1.19M. The position accounts for 0.12% of the portfolio, ranked #106.

Grove Bank & Trust first reported a position in ELV in Q4 2015 and has held it in 27 quarters since. The position peaked at $1.23M in Q2 2025. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Grove Bank & Trust held 3,068 shares of Elevance Health worth $1.19M as of Q2 2026.
  • Grove Bank & Trust sold 526 Elevance Health shares in Q2 2026, an estimated $195K.
  • Elevance Health made up 0.12% of Grove Bank & Trust's portfolio in Q2 2026, its #106 holding.
  • Grove Bank & Trust first reported a position in Elevance Health in Q4 2015 and has held it in 27 quarters since.
  • Grove Bank & Trust's Elevance Health position peaked at $1.23M in Q2 2025.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.